Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Gemigliptin (tartrate) | 1374639-74-3 | 99.5% | 639.45 | 1 ML
SDP

Catalog No. 5000359503
Encompass_Preferred

Gemigliptin tartrate, also known as LC15-0444 tartrate, is a highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 of 10.3 nM for human recombinant DPP-4. It demonstrates potent anti-glycation properties and can be used in research concerning advanced glycation end products (AGE)-related diabetic complications.

  • Highly selective DPP-4 inhibitor.
  • Exhibits potent anti-glycation properties.
  • Useful for research on AGE-related diabetic complications.
  • Dose-dependently inhibits AGE-BSA formation.
  • Suppresses cross-linking of preformed AGE-BSA.

Catalog No. 50-003-59503 Supplier Medchemexpress LLC Supplier No. HY14892A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Gemigliptin tartrate, also known as LC15-0444 tartrate, is a highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 of 10.3 nM for human recombinant DPP-4. It demonstrates potent anti-glycation properties and can be used in research concerning advanced glycation end products (AGE)-related diabetic complications.

  • Highly selective DPP-4 inhibitor.
  • Exhibits potent anti-glycation properties.
  • Useful for research on AGE-related diabetic complications.
  • Dose-dependently inhibits AGE-BSA formation.
  • Suppresses cross-linking of preformed AGE-BSA.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.